ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,522Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 617

$715K Total Retail Price of All Prescriptions

Rank: 26 out of 617

629 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 629 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 629 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 17,055 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 860 841 1 2
FUROSEMIDE 734 702 2 4
LEVOTHYROXINE SODIUM 663 612 3 1
OMEPRAZOLE 630 533 4 3
METOPROLOL TARTRATE 550 508 5 11
LISINOPRIL 544 527 6 5
WARFARIN SODIUM 504 477 7 7
METOPROLOL SUCCINATE 449 442 8 12
HYDROCHLOROTHIAZIDE 379 379 9 13
AMLODIPINE BESYLATE 360 348 10 6
ATENOLOL 323 319 11 17
HYDROCODONE-ACETAMINOPHEN 293 230 S3 12 8
ALENDRONATE SODIUM 272 253 13 25
ALLOPURINOL 267 226 14 27
ATORVASTATIN CALCIUM 259 252 15 14
METFORMIN HCL 248 209 16 9
GABAPENTIN 245 224 17 16
POTASSIUM CHLORIDE 230 218 18 10
LOSARTAN-HYDROCHLOROTHIAZIDE 228 216 19 46
PRAVASTATIN SODIUM 222 215 20 21
ROPINIROLE HCL 213 178 21 66
LOSARTAN POTASSIUM 204 197 22 22
MELOXICAM 201 196 23 24
TAMSULOSIN HCL 197 196 24 26
DONEPEZIL HCL 196 196 25 30
PREDNISONE 178 157 26 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 175 27 29
SERTRALINE HCL 169 159 28 20
CITALOPRAM HBR 167 150 29 18
MIRTAZAPINE 149 137 30 50
ZOLPIDEM TARTRATE 145 126 31 23
PAROXETINE HCL 145 144 31 62
DIGOXIN 134 134 33 48
ISOSORBIDE MONONITRATE ER 129 129 34 52
ATENOLOL-CHLORTHALIDONE 128 125 35 142
FLUTICASONE PROPIONATE 117 107 36 36
BENAZEPRIL HCL 115 113 37 44
ENALAPRIL MALEATE 113 100 38 34
METOLAZONE 106 98 39 159
BUSPIRONE HCL 104 67 40 131
FENTANYL 103 103 S2 41 45
NAMENDA 103 94 41 35
LANTUS SOLOSTAR 102 100 43 115
METFORMIN HCL ER 97 85 44 72
TRIAMTERENE-HYDROCHLOROTHIAZID 92 92 45 122
PROAIR HFA 92 90 45 75
AMITRIPTYLINE HCL 87 78 R 47 56
CEPHALEXIN 84 79 48 68
TRAMADOL HCL 84 71 48 15
CLOPIDOGREL 84 79 48 53
CARVEDILOL 84 79 48 19
POLYETHYLENE GLYCOL 3350 84 84 48 32
CRESTOR 83 83 53 28
TRAZODONE HCL 82 56 54 51
DOXAZOSIN MESYLATE 81 81 55 79
SYMBICORT 80 76 56 141
LANTUS 79 73 57 39
FLUOXETINE HCL 78 68 58 73
VENLAFAXINE HCL ER 75 75 59 76
VYTORIN 74 74 60 160
GLIMEPIRIDE 73 73 61 33
CARBIDOPA-LEVODOPA 71 71 62 69
ACETAMINOPHEN-CODEINE 69 61 S3 63 138
NEXIUM 66 66 64 43
HUMALOG 65 64 65 152
CYMBALTA 65 62 65 49
ACTOS 65 59 65 85
ALBUTEROL SULFATE 64 63 68 112
DILTIAZEM ER 64 64 68 81
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 70 80
RISPERIDONE 62 39 71 71
TERAZOSIN HCL 62 62 71 96
AZITHROMYCIN 60 51 73 70
OXYBUTYNIN CHLORIDE ER 59 55 74 114
CLOTRIMAZOLE-BETAMETHASONE 57 51 75 175
SPIRIVA 56 56 76 61
PLAVIX 56 52 76 86
LYRICA 55 55 78 92
SYNTHROID 55 55 78 59
CIPROFLOXACIN HCL 55 53 78 60
VESICARE 52 38 81 95
ESCITALOPRAM OXALATE 51 51 82 65
LOVASTATIN 50 42 83 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.